Evidence map›Paper›PMID 28191309›Full record

ArticleAntimicrobial resistance and infection control2017

Co-existence of

Prabhu Raj Joshi, Mahesh Acharya, Trishna Kakshapati, Udomluk Leungtongkam, Rapee Thummeepak, Sutthirat Sitthisak

Abstract read
In one paragraph

Article in Antimicrobial resistance and infection control, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Genomic Epidemiology of NDM-1 Carbapenemase-ProducingAntibiotics (Basel, Switzerland) · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Phenotypic and Genotypic Characterization of Carbapenem-ResistantInternational journal of microbiology · 2026
    Article
  9. Carbapenem-ResistantMicroorganisms · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. The intricacies ofFrontiers in microbiology · 2025
    Review
  17. Article
  18. Plasmid-Mediated Spread of Carbapenem Resistance inAntibiotics (Basel, Switzerland) · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Prabhu Raj JoshiCentral Department of Microbiology, Tribhuvan University, Kirtipur, Kathmandu Nepal.
Mahesh AcharyaCentral Department of Microbiology, Tribhuvan University, Kirtipur, Kathmandu Nepal.
Trishna KakshapatiAnnapurna Neurological Institute and Allied Sciences, Maitighar, Kathmandu Nepal.
Udomluk LeungtongkamDepartment of Microbiology and Parasitology, Faculty of Medical Science, Naresuan University, Phitsanulok, Thailand.
Rapee ThummeepakDepartment of Microbiology and Parasitology, Faculty of Medical Science, Naresuan University, Phitsanulok, Thailand.
Sutthirat SitthisakDepartment of Microbiology and Parasitology, Faculty of Medical Science, Naresuan University, Phitsanulok, Thailand.ORCID 0000-0003-4992-7635

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMolecular analysis of carbapenem-resistant genes in

methods

resultsOf total 44 analyzed isolates, 97.7% (

conclusionWe found high prevalence of CR-AB and MDR-AB with

Indexed as

Acinetobacter baumanniiblaOXA-23 and blaNDM-1 carbapenemase genesCarbapenem resistance

Identifiers

PMID28191309
PMCPMC5297125

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.